Smith Interface Technologies, LLC v. Apple Inc.

District Court, S.D. California·Decided August 21, 2025·No. 3:23-cv-01187·Unknown

Opinion

SMITH INTERFACE TECHNOLOGIES, Case No.: 23-cv-1187-TWR-DTF LLC, REPORT AND Plaintiff, RECOMMENDATION ON MOTION v. TO STRIKE APPLE INC., Defendant. This Report and Recommendation is submitted to United States District Judge Todd W. Robinson pursuant to 28 U.S.C. § 636(b) and Civil Local Rules 72.1(c) of the United States District Court for the Southern District of California. Currently before the Court is Defendant’s Motion to Strike (Doc. No. 155-1) and Plaintiff’s Opposition (Doc. No. 159). On July 17, 2025, the Court held a telephonic Discovery Dispute Conference where the issue of Plaintiff’s infringement contentions and related interrogatory requests was discussed. The Court, therefore, finds this issue suitable for determination on the papers submitted and without further oral argument in accordance with Civil Local Rule 7.1(d)(1). For the reasons stated below, the Court RECOMMENDS that Defendant’s motion to strike be GRANTED. /// /// Inventor Michael Smith “developed new advanced input and output techniques for mobile user interfaces [, “UIs”] such as “multi-part gestures, where users can take successive actions, such as by touching, tapping, long-pressing, or sliding, and receive feedback at each step, whether visual or tactile (or both).” (See Third Amended Complaint (“TAC”) ¶ 19.) “These mobile UI advances resulted in numerous patents, including U.S. Patent Nos. 10,642,413 (the “’413 Patent”); 10,649,578 (the “’578 Patent”); 10,649,580 (the “’580 Patent”); 10,656,754 (the “’754 Patent”); 10,656,755 (the “’755 Patent”); 10,656,758 (the “’758 Patent”); 10,671,212 (the “’212 Patent”); 10,725,581 (the “’581 Patent”); 10,936,114 (the “’114 Patent”); and 11,740,727 (the “’727 Patent”) (collectively, the “Asserted Patents”).” (Id. ¶ 17.) The Asserted Patents are all continuation[s] of and claim[] priority to numerous patents, patent applications, and provisional patent applications dating back to U.S. Provisional Application No. 61/515,835, filed August 5, 2011.” (See id. ¶¶ 21-30.) Smith is the sole named inventor of the Asserted Patents, all of which are assigned solely to Plaintiff Smith Interface. (See id.) On June 27, 2023, Smith Interface filed the instant action against Apple, asserting nine claims of patent infringement as to each of the ’413, ’578, ’580, ’754, ’755, ’758, ’212, ’581, and ’114 Patents (the “Original Asserted Patents”), (see generally Doc. No. 1 (“Compl.”)). Smith Interface amended its Complaint on August 29, 2023 to add a claim for infringement of the ‘727 Patent that has just issued. (See generally, Doc. No. 22, First Amended Complaint). On October 26, 2023, after being given leave of court, Smith Interface filed a Second Amended Complaint (“SAC”). (See generally Doc. No. 44.) Apple promptly filed a motion to dismiss the SAC’s claims for willful and indirect infringement. On March 5, 2024, the Court granted-in-part and denied-in-part Apple’s motion to dismiss and granted Smith Interface leave to file an amended complaint. (Doc. No. 63.) On March 19, 2024, Smith Interface filed the operative TAC. (Doc. No. 66.) On October 2, 2024, the Court granted Apple’s motion to stay (Doc. No. 127) pending the PTABS’s initial determinations in the inter partes review (“IPR”) proceedings, following Apple’s filing of IPR petitions challenging the validity of each of Smith Interface’s ten asserted patents, (Doc. No. 140.) On March 5, 2025, the stay was lifted, and Smith Interfaces action against Apple was reduced to a subset of claims from the ’754 Patent. (Doc. No. 141.) On June 25, 2025, Smith Interface served its second amended infringement contentions pursuant to Patent Local Rule 3.6(a) and the Court’s scheduling order. Under 35 U.S.C. § 271(b) “whoever actively induces infringement of a patent shall be liable as an infringer.” A claim for induced infringement requires that “there has been direct infringement by a third party and that the alleged infringer affirmatively induced that infringement with knowledge that the induced acts constituted patent infringement.” Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., 104 F.4th 1370, 1377 (Fed. Cir. 2024). Thus, liability under § 271(b) requires an affirmative act encouraging infringement. Indeed, as the Supreme Court has informed “[t]he addition of the adverb ‘actively’ suggests that the inducement must involve the taking of affirmative steps to bring about the desired result.” Global-Tech Appliances, Inc. v. SEB S.A., 563 U.S. 754, 760 (2011) (internal citation omitted). Whereas 35 U.S.C. § 271(f)(1) provides: Whoever without authority supplies or causes to be supplied in or from the United States all or a substantial portion of the components of a patented invention, where such components are uncombined in whole or in part, in such manner as to actively induce the combination of such components outside of the United States in a manner that would infringe the patent if such combination occurred within the United States, shall be liable as an infringer. Liability under § 271(f) requires that the claimant demonstrate that the alleged infringer “actively induce” the combination of the components. The “actively induced” requirement has been given the same meaning in both § 271(b) and § 271(f)(1). See e.g., Dialect, LLC v. Amazon.com, Inc., No. 1:23CV581 (DJN), 2024 WL 4010111, at *4 (E.D. Va. Aug. 30, 2024) (noting that “Section 271(f)(1) bears more than a passing resemblance to 35 U.S.C. § 271(b)” and that “basic principles of statutory interpretation strong support giving the phrase ‘actively induce’ the same meaning in both § 271(b) and § 271(f)(1)”). With respect to indirect infringement contentions brought under 35 U.S.C. § 271(b) and (f), Patent Local Rule 3-1(d), requires: [f]or each claim which is alleged to have been indirectly infringed, an identification of any direct infringement and a description of the acts of the alleged indirect infringer that contribute to or are inducing that direct infringement. In so far as alleged direct infringement is based on joint acts of multiple parties, the role of each such party in the direct infringement must be described. The purpose of the Court’s Patent Local Rules is “to require parties to crystallize their theories of the case early in the litigation and to adhere to those theories once they have been disclosed.” CliniComp Int'l, Inc. v. Cerner Corp., No. 17-cv-02479-GPC (DEB), 2022 WL 16985003, at *12 (S.D. Cal. Nov. 15, 2022) (quoting Wi-LAN Inc. v. LG Elecs., Inc., No. 18-CV-01577-H-BGS, 2019 WL 5790999, at *2 (S.D. Cal. Sept. 18, 2019)). “A district court has wide discretion in enforcing the Patent Local Rules.” Pelican Int’l, Inc. v. Hobie Cat Co., No. 3:20-cv-02390-RSH-MS, 2023 WL 2127995, at *4 (S.D. Cal. Feb. 10, 2023) (internal citation omitted); see also Howmedica Osteonics Corp. v. Zimmer, Inc., 822 F.3d 1312, 1320 (Fed. Cir. 2016) (reviewing “a district court's application of its local rules for abuse of discretion”). Apple moves to strike Smith Interface’s indirect infringement contentions, asserting that Smith Interface has failed to articulate the necessary and required facts to support these theories. I. Section 271(b) Contentions Are Deficient. First Apple argues that Smith Interface’s 35 U.S.C. §

Smith Interface Technologies, LLC v. Apple Inc., (S.D. Cal. 2025).

Smith Interface Technologies, LLC v. Apple Inc. (Smith Interface Technologies, LLC v. Apple Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Global-Tech Appliances, Inc. v. SEB S. A.
131 S. Ct. 2060 (Supreme Court, 2011)
Howmedica Osteonics Corp. v. Zimmer, Inc.
822 F.3d 1312 (Federal Circuit, 2016)
McGuire v. Russell Miller, Inc.
1 F.3d 1306 (Second Circuit, 1993)
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
104 F.4th 1370 (Federal Circuit, 2024)